NCT05062655

Brief Summary

From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient. Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity. The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management. This new organisation is part of the policy of continuous improvement of the quality and safety of care

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 3, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 30, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2022

Completed
Last Updated

January 24, 2022

Status Verified

September 1, 2021

Enrollment Period

1.3 years

First QC Date

September 21, 2021

Last Update Submit

January 7, 2022

Conditions

Hospitalized Patient

Keywords

Medication reconciliationContinuityTown-hospital network

Outcome Measures

Primary Outcomes (1)

  • Value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment

    Value of coordinated pathway is evaluated by number of days of treatment interruption between patient discharge and provision of treatment to the patient

    1 month after inclusion

Study Arms (2)

Drug reconciliation

EXPERIMENTAL

Drug reconciliation and transmission to pharmacist

Other: Drug reconciliation

standard

NO INTERVENTION

Interventions

Drug reconciliationOTHER

Drug reconciliation information transmission to pharmacist interview with the patient

Drug reconciliation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • hospitalized patient
  • Patient with a drug treatment with a particular mode of supply
  • Paediatric patient or an adult patient.

You may not qualify if:

  • Patient under curatorship or guardianship
  • Patient residing abroad
  • No free, informed and written consent obtained

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Du Mans

Le Mans, 72000, France

RECRUITING

Central Study Contacts

Christelle JADEAU

CONTACT

02 44 71 07 81cjadeau@ch-lemans.fr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2021

First Posted

September 30, 2021

Study Start

August 3, 2021

Primary Completion

December 8, 2022

Study Completion

December 8, 2022

Last Updated

January 24, 2022

Record last verified: 2021-09

Locations

FR(1)